Cargando…
Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality
Immunotherapy has reshaped the field of cancer therapeutics but the population that benefits are small in many tumor types, warranting a companion diagnostic test. While immunohistochemistry (IHC) for programmed death-ligand 1 (PD-L1) or mismatch repair (MMR) and polymerase chain reaction (PCR) for...
Autores principales: | Vathiotis, Ioannis A., Yang, Zhi, Reeves, Jason, Toki, Maria, Aung, Thazin Nwe, Wong, Pok Fai, Kluger, Harriet, Syrigos, Konstantinos N., Warren, Sarah, Rimm, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163775/ https://www.ncbi.nlm.nih.gov/pubmed/34050252 http://dx.doi.org/10.1038/s41698-021-00184-1 |
Ejemplares similares
-
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade
por: Vathiotis, Ioannis A., et al.
Publicado: (2022) -
Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer
por: Vathiotis, Ioannis A., et al.
Publicado: (2021) -
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer
por: MacNeil, Tyler, et al.
Publicado: (2021) -
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma
por: Gavrielatou, Niki, et al.
Publicado: (2023) -
Spatial characterization and quantification of CD40 expression across cancer types
por: Bates, Katherine M., et al.
Publicado: (2023)